News
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...
Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.
GLP-1 blockbusters like semaglutide and tirzepatide are widely used for diabetes and weight loss but come with some nasty ...
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular disease.
The study found that weight regain varied with follow-up, with participants experiencing weight regain at eight, 12, and 20 ...
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...
A new study in mice shows that tirzepatide—the active ingredient in the popular drugs Mounjaro and Zepbound—not only helps shed pounds but may also slow or reduce the growth of breast cancer tumors ...
1d
India Today on MSNWeight-loss drugs work, but here's when the weight starts to returnNew study reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Here's what they found.
A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results